Pharma Journalist -

Gilead Sciences, Inc. announced the U.S. Food and Drug Administration (FDA) has approved Trodelvy (sacituzumab govitecan-hziy) for the treatment of adult patients with unresectable…
Read More...

Sepsis is a silent and mysterious killer that makes up nearly a quarter of deaths worldwide. This disease often leads to shock and multiple organ failure, and because of its enigmatic…
Read More...

Pliant Therapeutics, Inc., a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, announced that the U.S. Food…
Read More...

PharmaTher Holdings Ltd. announced that the U.S. Food and Drug Administration (“FDA”) has granted orphan drug designation to KETARX (racemic ketamine) for the treatment of Rett…
Read More...

Purple Biotech Ltd. announced that it has entered into an agreement for the acquisition of Immunorizon Ltd., a private company developing potential multi-specific T and NK cell engager…
Read More...

Tonix Pharmaceuticals Holding Corp. announced an agreement whereby Tonix has acquired all of the assets of Healion Bio, Inc. (Healion) including its entire portfolio of next-generation…
Read More...

Karuna Therapeutics, Inc. and GFB (ABC), LLC, assignee of the Goldfinch Bio assignment estate, announced their entry into an exclusive license agreement under which Karuna will obtain…
Read More...

4D Molecular Therapeutics, a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines, announced FDA clearance of the…
Read More...

Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the development of cancer medicines and treatments through an innovative drug development model,…
Read More...

GSK plc announced that the US Food and Drug Administration (FDA) has approved Jesduvroq (daprodustat), an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), for the…
Read More...